Page last updated: 2024-08-23

bromocriptine and Dyskinesia, Drug-Induced

bromocriptine has been researched along with Dyskinesia, Drug-Induced in 63 studies

Research

Studies (63)

Timeframe	Studies, this research(%)	All Research%
pre-1990	32 (50.79)	18.7374
1990's	16 (25.40)	18.2507
2000's	13 (20.63)	29.6817
2010's	2 (3.17)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Montgomery, EB	1
Dunnett, SB; Lane, EL	1
Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H	1
Kondo, T	1
Cannizzaro, C; Jenner, P; Pearce, RK; Rose, S; Tel, BC; Zeng, BY	1
Cho, IS; Ha, JH; Im, JH; Lee, MC	1
Burger, E; Härtter, S; Kvernmo, T	1
Chase, TN; Tamminga, CA	1
Lustig, A; Moscovici, M; Ringwald, E; Spiegel, R; Vamos, E	1
Weiner, M	1
Andersson, U; Gunne, LM; Häggström, JE	1
Tegeler, J; Wöller, W	1
Evans, WS; Thorner, MO; Vance, ML	1
Destee, A	1
Morris, JG	2
Cutler, NR; Jeste, DV; Karoum, F; Kaufmann, CA	1
Brenner, R; Lesser, M; Lieberman, J	1
Haas, JA; Lakke, JP	1
Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF; Vern, B	1
Tamminga, CA	1
Ané, M; Blin, O; Fabre, N; Montastruc, JL; Poulik, J; Rascol, A; Rascol, O; Sabatini, U; Senard, JM	1
Montastruc, JL; Rascol, A; Rascol, O; Senard, JM	1
Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR	1
Agid, Y; Bonnet, AM; Dubois, B; Marconi, R; Serre, I	1
Durelle, G; Fuseau, A; Lombertie, ER	1
Brown, D; Factor, SA; Molho, ES; Podskalny, GD	1
Goto, I; Kanazawa, I; Kowa, H; Kuno, S; Mizuno, Y; Ogawa, N; Tashiro, K; Yanagisawa, N	2
Blümner, E; Danielczyk, W; Gerlach, M; Kaiser, HJ; Kraus, PH; Letzel, H; Przuntek, H; Riederer, P; Uberla, K; Welzel, D	1
Banerji, T; Jenner, P; Marsden, CD; Pearce, RK	1
Brotchie, JM; Crossman, AR; Henry, B	1
Sunohara, N	1
Finken, MJ; Ramaker, C; van de Beek, WJ; van Hilten, BJ	1
Clarke C, E; Speller J, M	1
Finken, MJ; Ramaker, C; Van de Beek, WJ; van Hilten, JJ	1
Clarke, CE; Speller, JM	1
Clarke, CE; Deane, KD	1
Ben-Shlomo, Y; Head, J; Katzenschlager, R; Lees, AJ	1
Andersson, M; Cenci, MA; Kirik, D; Lundblad, M; Wierup, N; Winkler, C	1
Brooks, DJ; Brunt, ER; Korczyn, AD; Montastruc, JL; Stocchi, F	1
Pöldinger, W	1
Ringwald, E	1
Lander, CM; Lees, A; Stern, G	1
Lance, JW; Mackenzie, RA	1
List, SJ; Seeman, P	1
Barnes, TR; Kidger, T; Taylor, PJ	1
Bédard, P; Marsden, CD; Parkes, JD	1
Debono, AG; Marsden, CD; Parkes, JD	1
Leite, I; Lima, B	1
Haba, K; Mizukawa, K; Ogawa, N; Sato, H	1
Chee, KY; Sachdev, P	1
Montastruc, JL; Rascol, A; Rascol, O	1
Alvir, J; Kane, JM; Lieberman, JA; Mukherjee, S	1
Alvir, J; Fleischhacker, WW; Lieberman, JA; Perovich, RM	1
Casey, DE	1
Bentsen, BS; Gillette, GM; Haggerty, JJ	1
Mondal, BK; Mondal, KN	1
Wermuth, L	1
Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM	1
Bonomo, V; Parisi, R; Rapisarda, V	1
Lenox, RH; Saran, BM; Weaver, LA	1
Luquin, MR; Martínez Lage, JM; Obeso, JA	1

Reviews

13 review(s) available for bromocriptine and Dyskinesia, Drug-Induced

Article	Year
Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists. Journal of neurology, 2002, Volume: 249 Suppl 2 Topics: Animals; Antiparkinson Agents; Bromocriptine; Contraindications; Disease Models, Animal; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine	2002
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clinical therapeutics, 2006, Volume: 28, Issue:8 Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Heart Valve Diseases; Humans; Indoles; Pergolide; Pulmonary Fibrosis; Receptors, Dopamine	2006
Update on antiparkinsonian agents. Geriatrics, 1982, Volume: 37, Issue:9 Topics: Aged; Amantadine; Antiparkinson Agents; Blood-Brain Barrier; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Selegiline; Vascular Resistance	1982
Drugs five years later. Bromocriptine. Annals of internal medicine, 1984, Volume: 100, Issue:1 Topics: Acromegaly; Adenoma; Bromocriptine; Dyskinesia, Drug-Induced; Edema; Female; Growth Hormone; Hepatic Encephalopathy; Humans; Huntington Disease; Infertility, Female; Lactation; Luteal Phase; Male; Mental Disorders; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Premenstrual Syndrome; Prolactin	1984
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)]. LARC medical, 1984, Volume: 4, Issue:2 Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Male; Movement Disorders; Nervous System Diseases; Parkinson Disease; Shy-Drager Syndrome; Syndrome; Torticollis	1984
The management of Parkinson's disease. Australian and New Zealand journal of medicine, 1982, Volume: 12, Issue:2 Topics: Adult; Aged; Amantadine; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease	1982
[Toxic and adverse neurological effects of anti-parkinsonian drugs]. Ryoikibetsu shokogun shirizu, 1999, Issue:27 Pt 2 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders	1999
The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Randomized Controlled Trials as Topic; Treatment Outcome	2000
Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide	2000
Bromocriptine for levodopa-induced motor complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease	2000
Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Parkinson Disease	2000
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2001, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic	2001
Tardive dyskinesia: epidemiologic factors as a guide for prevention and management. Advances in biochemical psychopharmacology, 1985, Volume: 40 Topics: Age Factors; Animals; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Haplorhini; Humans; Levodopa; Parasympatholytics; Reserpine; Risk	1985

Trials

20 trial(s) available for bromocriptine and Dyskinesia, Drug-Induced

Article	Year
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:3 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3	2013
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study. Journal of neurology, 2003, Volume: 250, Issue:1 Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Treatment Outcome	2003
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)]. LARC medical, 1984, Volume: 4, Issue:2 Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Male; Movement Disorders; Nervous System Diseases; Parkinson Disease; Shy-Drager Syndrome; Syndrome; Torticollis	1984
Bromocriptine: low-dose therapy in Parkinson disease. Neurology, 1982, Volume: 32, Issue:6 Topics: Aged; Bromocriptine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Tremor	1982
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:4 Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Naltrexone; Neurologic Examination; Parkinson Disease	1994
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up. Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:9 Topics: Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Prospective Studies	1994
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide	1995
[Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia]. Annales medico-psychologiques, 1995, Volume: 153, Issue:8 Topics: Adult; Antipsychotic Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Hyperprolactinemia; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Treatment Outcome	1995
Eight-year follow-up study of bromocriptine monotherapy for Parkinson's disease. European neurology, 1996, Volume: 36 Suppl 1 Topics: Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Japan; Levodopa; Male; Middle Aged; Parkinson Disease	1996
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study. Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:6 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Incidence; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Parkinson Disease; Prospective Studies; Time Factors	1996
Nine-year follow-up study of bromocriptine monotherapy for Parkinson's disease. European neurology, 1997, Volume: 38 Suppl 1 Topics: Aged; Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1997
Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial. Neurology, 2001, Nov-13, Volume: 57, Issue:9 Topics: Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Disability Evaluation; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Incidence; Levodopa; Male; Parkinson Disease; Selegiline; Treatment Outcome	2001
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa. Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Indoles; Levodopa; Logistic Models; Male; Middle Aged; Odds Ratio; Parkinson Disease	2002
Therapy of extrapyramidal side effects, with particular reference to persistent dyskinesia and lithium tremor. International pharmacopsychiatry, 1978, Volume: 13, Issue:4 Topics: Adolescent; Adult; Amantadine; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Male; Middle Aged; Oxprenolol; Tremor	1978
[Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)]. Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1978, Volume: 11, Issue:6 Topics: Antipsychotic Agents; Bromocriptine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Levodopa; Receptors, Dopamine; Schizophrenia; Time Factors; Trihexyphenidyl	1978
An evaluation of bromocriptine in the treatment of Parkinson's disease. Clinical and experimental neurology, 1978, Volume: 15 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease	1978
Pharmacological characterization of tardive akathisia. Biological psychiatry, 1990, Nov-01, Volume: 28, Issue:9 Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztropine; Brain; Bromocriptine; Chronic Disease; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Infusions, Intravenous; Male; Metoclopramide; Metoprolol; Physostigmine; Propranolol; Psychomotor Agitation; Schizophrenia, Paranoid	1990
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study]. Revue neurologique, 1990, Volume: 146, Issue:2 Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Disorders; Randomized Controlled Trials as Topic	1990
Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy. Archives of general psychiatry, 1989, Volume: 46, Issue:10 Topics: Adolescent; Adult; Antipsychotic Agents; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Placebos; Receptors, Dopamine	1989
The behavioral toxicity of bromocriptine in patients with psychiatric illness. Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:6 Topics: Adult; Antipsychotic Agents; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Substance-Related Disorders	1989

Other Studies

31 other study(ies) available for bromocriptine and Dyskinesia, Drug-Induced

Article	Year
Agonist or levodopa for Parkinson disease? Ultimately, it doesn't matter; neither is good enough. Neurology, 2009, Jun-16, Volume: 72, Issue:24 Topics: Bromocriptine; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Indoles; Levodopa; Parkinson Disease; Practice Patterns, Physicians'; Prevalence; Randomized Controlled Trials as Topic; Time; Treatment Outcome	2009
Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat. Behavioural brain research, 2010, Nov-12, Volume: 213, Issue:1 Topics: Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Oxidopamine; Parkinsonian Disorders; Piribedil; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotation; Time Factors	2010
Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets. Neuroscience, 2002, Volume: 115, Issue:4 Topics: Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Male; Mazindol; Neostriatum; Neural Pathways; Neuropeptides; Parkinsonian Disorders; Protein Precursors; Receptors, Purinergic P1; RNA, Messenger; Tachykinins	2002
Bromocriptine and CF 25-397 in the treatment of tardive dyskinesia. Archives of neurology, 1980, Volume: 37, Issue:4 Topics: Adult; Antipsychotic Agents; Bromocriptine; Double-Blind Method; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Male; Pyridines	1980
[Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)]. Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1980, Volume: 13, Issue:6 Topics: Adult; Antipsychotic Agents; Bromocriptine; Chlorpromazine; Chronic Disease; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Prolactin; Schizophrenia	1980
Bromocriptine in tardive dyskinesia. Pharmacopsychiatria, 1982, Volume: 15, Issue:5 Topics: Aged; Alcoholism; Antipsychotic Agents; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Schizophrenia; Time Factors	1982
[Therapeutic measures in tardive dyskinesia]. Fortschritte der Neurologie-Psychiatrie, 1983, Volume: 51, Issue:6 Topics: Age Factors; Amantadine; Antipsychotic Agents; Baclofen; Benzodiazepines; Bromocriptine; Deanol; Dihydroxyphenylalanine; Dyskinesia, Drug-Induced; Humans; Phosphatidylcholines; Schizophrenia; Valproic Acid	1983
The drug treatment of Parkinson's disease. Australian family physician, 1984, Volume: 13, Issue:5 Suppl Topics: Amantadine; Bromocriptine; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parasympatholytics; Parkinson Disease	1984
Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disorders. Biological psychiatry, 1983, Volume: 18, Issue:9 Topics: Adult; Apomorphine; Bromocriptine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male	1983
Is bromocriptine a dopamine antagonist treatment? Archives of general psychiatry, 1983, Volume: 40, Issue:4 Topics: Bromocriptine; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans	1983
[Bromocriptine in the treatment of patients with parkinsonism and dyskinesias induced by levodopa]. Nederlands tijdschrift voor geneeskunde, 1982, Apr-17, Volume: 126, Issue:16 Topics: Adult; Aged; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1982
Antipsychotic and antidyskinetic properties of ergot dopamine agonists. Advances in biochemical psychopharmacology, 1980, Volume: 23 Topics: Bromocriptine; Dyskinesia, Drug-Induced; Ergot Alkaloids; Humans; Movement Disorders; Psychotic Disorders; Receptors, Dopamine	1980
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2 Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1994
The effect of dancing on dystonia. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:2 Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dancing; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Psychotic Disorders; Trihexyphenidyl; Vitamin E	1996
De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Male; Motor Skills; Neurologic Examination; Parkinson Disease, Secondary; Receptors, Dopamine D2	1998
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Experimental neurology, 1998, Volume: 151, Issue:2 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Clonidine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Levodopa; Lisuride; Locomotion; Male; Mazindol; Methoxydimethyltryptamines; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Rats; Rats, Sprague-Dawley; Sympatholytics; Tritium; Yohimbine	1998
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. The European journal of neuroscience, 2002, Volume: 15, Issue:1 Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Dyskinesia, Drug-Induced; Female; Gait; Levodopa; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotation; Stereotyped Behavior; Sympatholytics	2002
Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl. Clinical and experimental neurology, 1979, Volume: 16 Topics: Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Phenethylamines; Selegiline	1979
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats. Life sciences, 1979, Apr-16, Volume: 24, Issue:16 Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Drug; Spiperone	1979
On the use of dopamine agonists in tardive dyskinesia. The American journal of psychiatry, 1978, Volume: 135, Issue:1 Topics: Bromocriptine; Dyskinesia, Drug-Induced; Receptors, Dopamine	1978
Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias. British medical journal, 1978, Apr-15, Volume: 1, Issue:6118 Topics: Aged; Benzimidazoles; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1978
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa. Journal of neurology, neurosurgery, and psychiatry, 1976, Volume: 39, Issue:11 Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Follow-Up Studies; Growth Hormone; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Parkinson Disease; Receptors, Dopamine	1976
[Dyskinesia induced by isolated and low-dose bromocriptine]. Acta medica portuguesa, 1992, Volume: 5, Issue:6 Topics: Aged; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans	1992
Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile. European neurology, 1990, Volume: 30 Suppl 1 Topics: Animals; Apomorphine; Autoradiography; Benzazepines; Brain Chemistry; Bromocriptine; Ceruletide; Dyskinesia, Drug-Induced; Levodopa; Male; Neurotoxins; Neurotransmitter Agents; Nitriles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Muscarinic	1990
Neuroleptic malignant syndrome superimposed on tardive dyskinesia. The British journal of psychiatry : the journal of mental science, 1987, Volume: 150 Topics: Adult; Antipsychotic Agents; Bromocriptine; Dyskinesia, Drug-Induced; Humans; Male; Neuroleptic Malignant Syndrome	1987
Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy. Pharmatherapeutica, 1986, Volume: 4, Issue:9 Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Confusion; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Hydrazines; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease	1986
Outpatient treatment of Parkinson's disease. European neurology, 1988, Volume: 28, Issue:3 Topics: Ambulatory Care; Benserazide; Bromocriptine; Carboxy-Lyases; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Retrospective Studies	1988
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Neurology, 1985, Volume: 35, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors	1985
Long-acting therapy of schizophrenia. Advances in biochemical psychopharmacology, 1985, Volume: 40 Topics: Adolescent; Adult; Antiparkinson Agents; Benzodiazepines; Biofeedback, Psychology; Bromocriptine; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Pimozide; Schizophrenia; Trimeprazine	1985
Tardive dyskinesia: clinical and neuroendocrine response to low dose bromocriptine. Journal of clinical psychopharmacology, 1985, Volume: 5, Issue:5 Topics: Bromocriptine; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Male; Prolactin	1985
[Oral lisuride in Parkinson's disease]. Medicina clinica, 1985, Sep-21, Volume: 85, Issue:8 Topics: Adult; Aged; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease	1985